Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2008
07/22/2008CA2163805C Novel activating factor of leukocytes
07/22/2008CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto
07/22/2008CA1341578C Plants with modified stamen cells
07/17/2008WO2008086296A2 Acid ceramidase and cell survival
07/17/2008WO2008086147A1 Compositions and methods for the repair and regeneration of cartilage and/or bone
07/17/2008WO2008086040A1 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
07/17/2008WO2008085962A2 Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
07/17/2008WO2008085912A1 Compositions of and methods of using sulfatases from flavobacterium heparinum
07/17/2008WO2008085891A1 Oocyte spindle-associated factors improve somatic cell cloning
07/17/2008WO2008085563A1 Recombinant viral proteins and particles
07/17/2008WO2008085551A2 Smallpox monoclonal antibody
07/17/2008WO2008085543A2 Multimeric elp fusion constructs
07/17/2008WO2008085191A1 Polypeptide inhibitors of hsp27 kinase and uses therefor
07/17/2008WO2008084857A1 Three-dimensional cell culture carrier and cell culture method using the same
07/17/2008WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof
07/17/2008WO2008084401A2 Composition and method for enabling proliferation of pluripotent stem cells
07/17/2008WO2008084329A2 Novel rucola plants with cytoplasmic male sterility (cms)
07/17/2008WO2008084069A1 A method for expanding monocytes
07/17/2008WO2008083987A1 Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells
07/17/2008WO2008083962A1 Provision of new cardiomyocyte progenitor cells and cardiomyocytes derived therefrom
07/17/2008WO2008066691A3 Tes7 and antibodies that bind thereto
07/17/2008WO2008063779A9 Cells expressing alpha-synuclein and uses therefor
07/17/2008WO2008052187A3 Antibodies and immunoconjugates and uses therefor
07/17/2008WO2008040027A9 Directed differentiation and maturation of stem cell-derived cardiomyocytes
07/17/2008WO2008027534A3 Transgenic plants with enhanced drought-resistance and method for producing the plants
07/17/2008WO2008018903A3 Proteins and polynucleotides of vibrio cholerae
07/17/2008WO2008010101A3 Antagonist antibody against epha2 for the treatment of cancer
07/17/2008WO2008002329A3 Isolation and expansion of animal cells in cell cultures
07/17/2008WO2007106497A3 Three-dimensional fabrication of biocompatible structures in anatomical shapes and dimensions for tissue engineering and organ replacement
07/17/2008US20080172764 Axmi-004, a delta-endotoxin gene and methods for its use
07/17/2008US20080172763 Nod-Factor Perception
07/17/2008US20080172762 Nucleotide sequences coding insecticidal protein for use in generation of insect resistant plants
07/17/2008US20080172759 Transgenic plant comprising expression vector coding genes which confer salinity, drought, temperature, metal, chemical and/or pathogenic resistance
07/17/2008US20080172758 Plant Galactinol Synthase Homologs
07/17/2008US20080172753 Transgenic seed for propgation of root rot resistant plants
07/17/2008US20080172752 Recombinant rodent animal model for identifying modulators for treatment of obesity and eating disorders
07/17/2008US20080171860 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
07/17/2008US20080171855 Polyvalent protein complex
07/17/2008US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation
07/17/2008US20080171755 4-(4-Benzo[1,3]dioxol-5-yl-1H-pyrazol-3-yl)-2-methylpyrimidine; affinity for activin receptor-like kinases 4/5; potent antagonists of these Transforming Growth Factor beta family type receptors; fibrosis; anticarcinogenic and -metastasis agents; demelination; expression inhibited by reducing signal path
07/17/2008US20080171714 Substances for preventing and treating autoimmune diseases
07/17/2008US20080171713 Substances for preventing and treating autoimmune diseases
07/17/2008US20080171710 Reducing oxidation in activated neural progenitor cells, islets of Langerhan or oligodendrocytes by contacting with an interupting agent; screening for pro-oxidation toxicants; cancer treatments; testing oxidation levels in patients at risk for autism, Alzheimer's Disease and environmental toxin exposure
07/17/2008US20080171690 Compositions and methods for the therapy and diagnosis of lung cancer
07/17/2008US20080171689 Having an extracellular domain of an FGFR1 polypeptide having an increased sialaytion level for more stability and a Fc fusion partner; antiproliferative, anticarcinogenic, antitumor agents; angiogenesis inhibitors;
07/17/2008US20080171390 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
07/17/2008US20080171388 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
07/17/2008US20080171387 Method for modulating cell proliferation
07/17/2008US20080171386 Using compartmentalized microinjection as tool in enhancing transfomation cells; improving exogenous gene expression
07/17/2008US20080171385 Cloning in presence of kinase inhibitor; feeder/animal free
07/17/2008US20080171384 Using post-partum placenta as source of stem cells tissues; tissue engineering; regenerative medicine
07/17/2008US20080171363 Interferon-alpha polypeptides and conjugates
07/17/2008US20080171362 Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity
07/17/2008US20080171360 Carbohydrate active hydrolase; biomass conversion for biofuels; ethanol production; enhancing feed compositions and food processing
07/17/2008US20080171350 Neural Cell Differentiation Method From Es Cells
07/17/2008US20080171349 Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
07/17/2008US20080171329 Gel Microdrops in Genetic Analysis
07/17/2008US20080171328 Vertebrate hedgehog polypeptide for use as tools in identifying modulators for use in treatment and prevention of nervous system disorders
07/17/2008US20080171092 Graft prosthesis, materials and methods
07/17/2008US20080171080 Methods of treating neurological conditions with hematopoeitic growth factors
07/17/2008US20080171062 Hepatitis B surface antigen (HBsAg); contain heterologous polyepitopes fused to the middle (M) envelope protein; useful in immunogenic compositions and as vaccines; expression vector for the production of virus-like particles comprising fusion proteins and S proteins of hepatitis B virus (HBV)
07/17/2008US20080171061 Using lentiviral peptide to ellicit CD8+ lymphocyte response to treat and prevent viral infection and viral associated cell proliferative disorders
07/17/2008US20080171059 Using transgenic cells expressing cancer antigen fusion as inducer of cell-mediated immune response targeting tumor cells; immunotherapy
07/17/2008US20080171058 Compositions and Methods For Synergistic Induction of Antitumor Immunity
07/17/2008US20080171056 Enhancing therapeutic efficacy of antitumor agents via concurrent expose to receptor specific immunoglobulins; tissue targeted therapy
07/17/2008US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection
07/17/2008US20080171048 Compositions and methods for the therapy and diagnosis of lung cancer
07/17/2008US20080171046 Novel proteins and nucleic acids encoding same
07/17/2008US20080171045 Compositions and Methods for Diagnosing and Treating Cancer
07/17/2008US20080171043 Cytotoxin conjugated immunoglobulin specific to tripeptide sequence (N'-Trp-Pro-Ile-C') of carcinoembryonic antigen for use in treatment and prevention of cell proliferative disorders
07/17/2008US20080171039 Zinc transporter protein (LIV-1) specific imunoglobulin for use in prevention and treatment of breast cancer
07/17/2008US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders
07/17/2008US20080171035 Mammalian cell membrane proteins; related reagents
07/17/2008US20080171033 Dipeptidyl peptidase-4 (DPP-4) (CD26) for use in treating diabetic retinopathy, psoriasis and arthritis; cytokine inhibition of interleukin-1 activity
07/17/2008US20080171027 Compositions and Methods for Elimination of Unwanted Cells
07/17/2008US20080171026 Using recombinant cells expressing measles virus H glycoprotein to target tumor cells fusion and removal; tissue target therapy
07/17/2008US20080171023 Nutrient broth comprising nervous system tissue is exposed to tumor associated antigen in order to ellicit enhanced CD8+T cell response; administered to cancer patient to treat cell proliferative disorders; immunotherapy
07/17/2008US20080171020 Method and composition for repairing epithelial and other cells and tissue
07/17/2008US20080171018 Serotype of adenovirus and uses thereof
07/17/2008US20080171014 Interleukin-13 binding proteins
07/17/2008DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses
07/17/2008DE112007000030T5 Verfahren zur Isolierung einer Haarfollikelstammzelle und Zusammensetzung für die Haarreproduktion A method for isolating a Haarfollikelstammzelle and Hair composition Reproduction
07/17/2008DE102007061873A1 Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien dessen Herstellung und Verwendung Silica sol degradable material for the production of biologically and / or resorbable materials whose silica gel preparation and use
07/17/2008CA2689296A1 Polypeptide inhibitors of hsp27 kinase and uses therefor
07/17/2008CA2684878A1 Provision of new cardiomyocyte progenitor cells and cardiomyocytes derived therefrom
07/17/2008CA2675313A1 Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells
07/17/2008CA2675032A1 Methods for increasing and mobilizing hematopoietic stem cells
07/17/2008CA2674849A1 Acid ceramidase and cell survival
07/17/2008CA2674795A1 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
07/17/2008CA2674493A1 Compositions of and methods of using sulfatases from flavobacterium heparinum
07/17/2008CA2662507A1 Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system
07/16/2008EP1944372A2 Bacillus thuringiensis toxin active against Lepidopteran pests
07/16/2008EP1944362A2 Methods for generating high titer helper-free preparations of recombinant AAV vectors
07/16/2008EP1944361A1 A method for expanding monocytes
07/16/2008EP1944360A1 Method for culturing dendritic cells (DC) and cytokine-induced killer cells (D-CIK) and applications thereof
07/16/2008EP1944321A2 Methods and compositions for determining the purity of chemically synthesized nucleic acids
07/16/2008EP1944319A1 T1R Taste Receptors and Genes Encoding Same
07/16/2008EP1944317A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/16/2008EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
07/16/2008EP1943336A1 Reconstructed living adipose tissue